SG Americas Securities
RPTX

SG Americas Securities’s Repare Therapeutics RPTX Stock Holding History

SG Americas Securities’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-34,354
Closed -$725K – 3358
2021
Q4 		$725K Buy
34,354
+7,587
+28% +$179K ﹤0.01% 1880
2021
Q3 		$702K Buy
+26,767
New +$865K ﹤0.01% 2217

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

SG Americas Securities's RPTX Position: Q1 2022 in Review

SG Americas Securities sold out of Repare Therapeutics (RPTX) in Q1 2022, closing a stake of 34,354 shares — an estimated $725K sold.

SG Americas Securities first reported a position in RPTX in Q3 2021 and held it in 2 quarters. The position peaked at $725K in Q4 2021. 62 funds tracked by Wall St. Rank hold RPTX as of Q1 2022.

  • SG Americas Securities reported no remaining Repare Therapeutics position as of Q1 2022 after selling out during the quarter.
  • SG Americas Securities sold 34,354 Repare Therapeutics shares in Q1 2022, an estimated $725K.
  • SG Americas Securities first reported a position in Repare Therapeutics in Q3 2021 and held it in 2 quarters.
  • SG Americas Securities's Repare Therapeutics position peaked at $725K in Q4 2021.
  • 62 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2022.

Based on SG Americas Securities's 13F filing for Q1 2022, filed 29 Apr 2022.